MN HF17 | 2023-2024 | 93rd Legislature
Status
Spectrum: Partisan Bill (Democrat 35-0)
Status: Introduced on January 4 2023 - 25% progression, died in committee
Action: 2023-02-08 - Committee report, to adopt as amended and re-refer to Health Finance and Policy
Pending: House Health Finance & Policy Committee
Text: Latest bill text (Engrossed) [PDF]
Status: Introduced on January 4 2023 - 25% progression, died in committee
Action: 2023-02-08 - Committee report, to adopt as amended and re-refer to Health Finance and Policy
Pending: House Health Finance & Policy Committee
Text: Latest bill text (Engrossed) [PDF]
Summary
Generic or off-patent drugs; excessive price increases prohibited, attorney general authorized to take action against price increases, sale withdrawal prohibited, prescription drug affordability board and advisory council established, prescription drug cost reviews and remedies provided, and money appropriated.
Title
Generic or off-patent drugs; excessive price increases prohibited, attorney general authorized to take action against price increases, sale withdrawal prohibited, prescription drug affordability board and advisory council established, prescription drug cost reviews and remedies provided, and money appropriated.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-02-08 | House | Committee report, to adopt as amended and re-refer to Health Finance and Policy |
| 2023-02-06 | House | Committee report, to adopt as amended and re-refer to State and Local Government Finance and Policy |
| 2023-01-26 | House | Committee report, to adopt as amended and re-refer to Judiciary Finance and Civil Law |
| 2023-01-11 | House | Author added Long |
| 2023-01-09 | House | Author added Pérez-Vega |
| 2023-01-04 | House | Introduction and first reading, referred to Commerce Finance and Policy |
Same As/Similar To
SF168 (Similar To) 2023-03-27 - Comm report: To pass as amended and re-refer to Judiciary and Public Safety
